Key result
Inactivated influenza vaccines provide only moderate efficacy because frequent mutations in the hemagglutinin component allow circulating strains to evade vaccine-induced antibodies.
Design
Editorial
Authors
Loading...
Highlights the challenges and moderate efficacy of current inactivated influenza vaccines due to viral mutations and strain mismatches.
Highlights the challenges and moderate efficacy of current inactivated influenza vaccines due to viral mutations and strain mismatches.
Stanley A. Plotkin (2018) conducted an editorial in Influenza. Inactivated influenza vaccine was evaluated. Inactivated influenza vaccines provide only moderate efficacy because frequent mutations in the hemagglutinin component allow circulating strains to evade vaccine-induced antibodies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: